Please turn JavaScript on
Find more feeds
Insider Monkey icon

Insider Monkey

Receive updates from Insider Monkey for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on Specificfeeds.

This way you won't miss any new article from Insider Monkey. Unsubscribe at any time.

Site title: Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  52.36 / day

Message History

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

AbbVie Inc. (NYSE:ABBV) spent years preparing investors for the decline of Humira, once one of the best-selling medicines in the world. Its fiscal Q2 2026 results provide some of the clearest evidence yet that the compa...


Read full story
Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

Patent expirations are forcing Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:


Read full story
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business?

The timing of Zoetis Inc.’s (NYSE:ZTS) latest regulatory win is particularly relevant for shareholders. Just one week after the animal-health company reported a 7% decline in U.S. revenue and an 11% drop in domestic com...


Read full story
Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Gilead Sciences, Inc. (NASDAQ:GILD) produced an unusual earnings report in fiscal Q2 2026. Its commercial portfolio delivered double-digit growth, and yet the company posted one of the largest quarterly losses i...


Read full story
AstraZeneca’s Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue?

AstraZeneca PLC (NYSE:AZN) investors received a reassuring earnings report at a sensitive point in the company’s growth story. H1 2026 core operating profit and core EPS rose 11%, while total revenue rose 6%, suppor...


Read full story